Literature DB >> 23674528

17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status.

Poneh Adib-Samii1, Natalia Rost, Matthew Traylor, William Devan, Alessandro Biffi, Silvia Lanfranconi, Kaitlin Fitzpatrick, Steve Bevan, Allison Kanakis, Valerie Valant, Andreas Gschwendtner, Rainer Malik, Alexa Richie, Dale Gamble, Helen Segal, Eugenio A Parati, Emilio Ciusani, Elizabeth G Holliday, Jane Maguire, Joanna Wardlaw, Bradford Worrall, Joshua Bis, Kerri L Wiggins, Will Longstreth, Steve J Kittner, Yu-Ching Cheng, Thomas Mosley, Guido J Falcone, Karen L Furie, Carlos Leiva-Salinas, Benison C Lau, Muhammed Saleem Khan, Pankaj Sharma, Myriam Fornage, Braxton D Mitchell, Bruce M Psaty, Cathie Sudlow, Christopher Levi, Giorgio B Boncoraglio, Peter M Rothwell, James Meschia, Martin Dichgans, Jonathan Rosand, Hugh S Markus.   

Abstract

BACKGROUND AND
PURPOSE: Recently, a novel locus at 17q25 was associated with white matter hyperintensities (WMH) on MRI in stroke-free individuals. We aimed to replicate the association with WMH volume (WMHV) in patients with ischemic stroke. If the association acts by promoting a small vessel arteriopathy, it might be expected to also associate with lacunar stroke.
METHODS: We quantified WMH on MRI in the stroke-free hemisphere of 2588 ischemic stroke cases. Association between WMHV and 6 single-nucleotide polymorphisms at chromosome 17q25 was assessed by linear regression. These single-nucleotide polymorphisms were also investigated for association with lacunar stroke in 1854 cases and 51 939 stroke-free controls from METASTROKE. Meta-analyses with previous reports and a genetic risk score approach were applied to identify other novel WMHV risk variants and uncover shared genetic contributions to WMHV in community participants without stroke and ischemic stroke.
RESULTS: Single-nucleotide polymorphisms at 17q25 were associated with WMHV in ischemic stroke, the most significant being rs9894383 (P=0.0006). In contrast, there was no association between any single-nucleotide polymorphism and lacunar stroke. A genetic risk score analysis revealed further genetic components to WMHV shared between community participants without stroke and ischemic stroke.
CONCLUSIONS: This study provides support for an association between the 17q25 locus and WMH. In contrast, it is not associated with lacunar stroke, suggesting that the association does not act by promoting small-vessel arteriopathy or the same arteriopathy responsible for lacunar infarction.

Entities:  

Keywords:  Genome-wide Association Study; genetics; leukoaraiosis; small-vessel disease; stroke

Mesh:

Year:  2013        PMID: 23674528      PMCID: PMC3771337          DOI: 10.1161/STROKEAHA.113.679936

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Authors:  Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

Review 2.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

Review 3.  Heterogeneity in age-related white matter changes.

Authors:  Reinhold Schmidt; Helena Schmidt; Johannes Haybaeck; Marisa Loitfelder; Serge Weis; Margherita Cavalieri; Stephan Seiler; Christian Enzinger; Stefan Ropele; Timo Erkinjuntti; Leonardo Pantoni; Philip Scheltens; Franz Fazekas; Kurt Jellinger
Journal:  Acta Neuropathol       Date:  2011-06-25       Impact factor: 17.088

4.  Replication study of chr17q25 with cerebral white matter lesion volume.

Authors:  Benjamin F J Verhaaren; Renske de Boer; Meike W Vernooij; Fernando Rivadeneira; André G Uitterlinden; Albert Hofman; Gabriel P Krestin; Aad van der Lugt; Wiro J Niessen; Monique M B Breteler; M Arfan Ikram
Journal:  Stroke       Date:  2011-08-25       Impact factor: 7.914

5.  Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI.

Authors:  R N Kaveer Nandigam; Yu-Wei Chen; Mahmut E Gurol; Jonathan Rosand; Steven M Greenberg; Eric E Smith
Journal:  J Neuroimaging       Date:  2007-01       Impact factor: 2.486

6.  Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

Authors:  J Grimaud; M Lai; J Thorpe; P Adeleine; L Wang; G J Barker; D L Plummer; P S Tofts; W I McDonald; D H Miller
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

Review 7.  Silent brain infarcts: a systematic review.

Authors:  Sarah E Vermeer; William T Longstreth; Peter J Koudstaal
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

Review 8.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26

9.  METAL: fast and efficient meta-analysis of genomewide association scans.

Authors:  Cristen J Willer; Yun Li; Gonçalo R Abecasis
Journal:  Bioinformatics       Date:  2010-07-08       Impact factor: 6.937

10.  A flexible and accurate genotype imputation method for the next generation of genome-wide association studies.

Authors:  Bryan N Howie; Peter Donnelly; Jonathan Marchini
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

View more
  27 in total

1.  White Matter Hyperintensity Associations with Cerebral Blood Flow in Elderly Subjects Stratified by Cerebrovascular Risk.

Authors:  Ahmed A Bahrani; David K Powell; Guoquiang Yu; Eleanor S Johnson; Gregory A Jicha; Charles D Smith
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-01-04       Impact factor: 2.136

Review 2.  White matter hyperintensities, cognitive impairment and dementia: an update.

Authors:  Niels D Prins; Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

Review 3.  Genetic factors in cerebral small vessel disease and their impact on stroke and dementia.

Authors:  Christof Haffner; Rainer Malik; Martin Dichgans
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 4.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.

Authors:  Cathy R Zhang; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Alison M Ayres; Karen L Furie; Jonathan Rosand; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-06       Impact factor: 2.136

6.  COX-2 rs20417 Polymorphism Is Associated with Stroke and White Matter Disease.

Authors:  Jamary Oliveira-Filho; Ana C P Ornellas; Cathy R Zhang; Luciana M B Oliveira; Théo Araújo-Santos; Valeria M Borges; Laís M G B Ventura; Francisco J F B Reis; Roque Aras; André M Fernandes; Jonathan Rosand; Steven M Greenberg; Karen L Furie; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-05-06       Impact factor: 2.136

Review 7.  Imaging Endophenotypes of Stroke as a Target for Genetic Studies.

Authors:  Xueqiu Jian; Myriam Fornage
Journal:  Stroke       Date:  2018-05-14       Impact factor: 7.914

8.  White matter disease as a biomarker for long-term cerebrovascular disease and dementia.

Authors:  Aurauma Chutinet; Natalia S Rost
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

9.  Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging.

Authors:  Xueqiu Jian; Claudia L Satizabal; Albert V Smith; Katharina Wittfeld; Joshua C Bis; Jennifer A Smith; Fang-Chi Hsu; Kwangsik Nho; Edith Hofer; Saskia P Hagenaars; Paul A Nyquist; Aniket Mishra; Hieab H H Adams; Shuo Li; Alexander Teumer; Wei Zhao; Barry I Freedman; Yasaman Saba; Lisa R Yanek; Ganesh Chauhan; Mark A van Buchem; Mary Cushman; Natalie A Royle; R Nick Bryan; Wiro J Niessen; Beverly G Windham; Anita L DeStefano; Mohamad Habes; Susan R Heckbert; Nicholette D Palmer; Cora E Lewis; Gudny Eiriksdottir; Pauline Maillard; Rasika A Mathias; Georg Homuth; Maria Del C Valdés-Hernández; Jasmin Divers; Alexa S Beiser; Sönke Langner; Kenneth M Rice; Mark E Bastin; Qiong Yang; Joseph A Maldjian; John M Starr; Stephen Sidney; Shannon L Risacher; André G Uitterlinden; Vilmundur G Gudnason; Matthias Nauck; Jerome I Rotter; Pamela J Schreiner; Eric Boerwinkle; Cornelia M van Duijn; Bernard Mazoyer; Bettina von Sarnowski; Rebecca F Gottesman; Daniel Levy; Sigurdur Sigurdsson; Meike W Vernooij; Stephen T Turner; Reinhold Schmidt; Joanna M Wardlaw; Bruce M Psaty; Thomas H Mosley; Charles S DeCarli; Andrew J Saykin; Donald W Bowden; Diane M Becker; Ian J Deary; Helena Schmidt; Sharon L R Kardia; M Arfan Ikram; Stéphanie Debette; Hans J Grabe; W T Longstreth; Sudha Seshadri; Lenore J Launer; Myriam Fornage
Journal:  Stroke       Date:  2018-08       Impact factor: 7.914

10.  White Matter Lesion Progression: Genome-Wide Search for Genetic Influences.

Authors:  Edith Hofer; Margherita Cavalieri; Joshua C Bis; Charles DeCarli; Myriam Fornage; Sigurdur Sigurdsson; Velandai Srikanth; Stella Trompet; Benjamin F J Verhaaren; Christiane Wolf; Qiong Yang; Hieab H H Adams; Philippe Amouyel; Alexa Beiser; Brendan M Buckley; Michele Callisaya; Ganesh Chauhan; Anton J M de Craen; Carole Dufouil; Cornelia M van Duijn; Ian Ford; Paul Freudenberger; Rebecca F Gottesman; Vilmundur Gudnason; Gerardo Heiss; Albert Hofman; Thomas Lumley; Oliver Martinez; Bernard Mazoyer; Chris Moran; Wiro J Niessen; Thanh Phan; Bruce M Psaty; Claudia L Satizabal; Naveed Sattar; Sabrina Schilling; Dean K Shibata; P Eline Slagboom; Albert Smith; David J Stott; Kent D Taylor; Russell Thomson; Anna M Töglhofer; Christophe Tzourio; Mark van Buchem; Jing Wang; Rudi G J Westendorp; B Gwen Windham; Meike W Vernooij; Alex Zijdenbos; Richard Beare; Stéphanie Debette; M Arfan Ikram; J Wouter Jukema; Lenore J Launer; W T Longstreth; Thomas H Mosley; Sudha Seshadri; Helena Schmidt; Reinhold Schmidt
Journal:  Stroke       Date:  2015-10-08       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.